Loading…
← CockpitCompetitor Analysis › NGVT Ingevity CorporationOpen in the cockpit ↗

Ingevity CorporationNGVTCompetitor analysis, valuation and peers

United States · USD·Materials›Chemicals: Major Diversified

Makes specialty chemicals derived from pine tree byproducts and activated carbon used in vehicle emissions control, spun off from WestRock.

Momentum weak 30
Mkt cap
$1.97B
US dollars, full cap
Free float
99%
of shares outstanding
$/day
$28.0M
20-day average traded
Fwd P/E
10.2×
forward earnings
ROIC−WACC
+14.4 pp
WACC 8.8%
Hurdle
-1 pp
Req g minus delivered
Next earnings
98 days
24 Feb 2027
Close · USD$58.31
1D-1.6%
1W-7.8%
1M-17.4%
3M-15.9%
6M-11.8%
YTD-1.5%
1Y+23.8%
ATR %4.5%
Beta1.32
52w lowhigh26.5% off high

What Ingevity does

Makes specialty chemicals derived from pine tree byproducts and activated carbon used in vehicle emissions control, spun off from WestRock.

The carbon business is paid per unit of emission-control carbon fitted in gasoline-vehicle fuel-vapour canisters, tied to gasoline and hybrid vehicle production and tightening rules rather than EV volumes. The chemicals business starts from crude tall oil, a pine by-product of paper pulping, and sells derivatives for road paving and other uses.

Products and services

  • Automotive activated carbon for fuel vapor emissions control
  • Pavement/asphalt performance chemicals from crude tall oil
  • Industrial specialties

Customers

  • Automakers (OEMs, emissions systems)
  • Road construction/paving companies

Where it sits in the supply chain

  • Materials
  • Chemicals: Major Diversified
  • Pine-based specialty chemicals and…

What could go right

  • Global vehicle emissions regulation tightening
  • Road construction and paving demand

What could go wrong

  • EV transition reducing gasoline vapor canister demand
  • Pine chemical feedstock cost and supply variability

Moat: narrow (process know-how, IP / patents, installed base). Leading global supplier of automotive charcoal canisters required for gasoline vapor emissions compliance.

Headquarters: North Charleston, South Carolina, US · Founded: 2016 · Employees: 1,500

Named competitors

Ingevity at a glance

Size Ingevity (NGVT) is a United States Materials company (Chemicals: Major Diversified) with a market value of $1.97B, the 1781st largest of 3,085 United States companies the cockpit tracks. Shares closed at $58.31 on 18 Nov 2026.

Performance Over six months the shares fell 11.8%, against -14.8% for the median peer and -2.2% for the United States market (cap-weighted) — 10th highest of 20 in its peer set.

Growth Revenue fell 11.6% over the last twelve months (peer median +11.3%); the operating margin is 25.5% (peer median 10.9%).

Valuation It trades at 10.2× forward earnings against a peer median of 23.5× (cheapest of 17).

Price implies For today's price to make sense, revenue must grow about -1% a year for seven years (Req g). Recent delivered growth is -1%, so the hurdle is -1 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 14.4 points above its cost of capital (8.8% WACC).

Short interest Short interest is 3.7% of the free float (30 Oct 2026).

Next results Next results expected around 24 Feb 2027 (exchange calendar; dates can move).

Relative performance

10012021 May 202621 Aug 202618 Nov 2026NGVT 89Peer median 84
Six months, rebased to 100: Ingevity against the median of its 20 peers (local-currency closes).

Ingevity financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$1.13B$1.17B$1.20B$1.69B$1.67B
Revenue growth—-3%-29%+2%—
Gross profit$456M$432M$435M$428M$541M
EBITDA$382M$368M$384M$395M$470M
Net income$61.4M-$167M-$430M-$5.40M$212M
Free cash flow$123M$274M$57.4M$95.3M$171M
Capital expenditure$57.6M$57.4M$71.2M$110M$142M
Total debt$1.18B$1.24B$1.45B$1.53B$1.53B

Quarterly statements and history in the cockpit →

Ingevity competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%+50%-20%-10%0%+10%1717IOSP4749688545002326FINEORGAARTIIND41144272AETHER457190002643HUNBRG688549PRIVISCL014680300596NGVT6-month return →1-month return →
Up and to the right = strong over both horizons. Ingevity is the large dot.

Fundamentals: revenue growth against valuation

0%+25%+50%+75%20×40×60×80×1717IOSP4749688545FINEORGAARTIIND41144272ACT0AETHER002643BRGPRIVISCLNGVTRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Ingevity is the large dot.

Capital: growth delivered against growth the price implies

0%+10%+20%+30%0%10%20%30%1717IOSPFINEORG4272ACT0002643BRGPRIVISCL300910NGVTGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Ingevity is the large dot.

Ingevity competitors and peer comparison

Head to head with its named competitors (NGVT vs CBT vs 3405.T)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Ingevity NGVT$1.97B-12%-12%26%10.2×-1.4%
Cabot CBT$3.80B-5%+1%14%11.3×-2.3%
Kuraray 3405.T$3.41B+14%+7%10%14.1×-5.0%

How Ingevity compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Ingevity against its 20 peers (data as of 18 Nov 2026)
MeasureNGVTPeer medianRank in peer set
1-month return-17.4%-8.2%4th lowest of 21
6-month return-11.8%-14.8%10th highest of 20
Distance from 52-week high-26.5%-33.9%10th highest of 21
Revenue growth (TTM)-11.6%+11.3%lowest of 21
Operating margin25.5%10.9%highest of 21
Forward P/E10.2×23.5×cheapest of 17
Growth the price implies (Req g, 7 yrs)-1.4%5.4%least demanding of 11
Growth delivered (Del g)-0.8%+8.0%lowest of 11
Hurdle (Req g minus delivered)-0.6 pp-2.4 pp5th most demanding of 11
ROIC minus cost of capital+14.4 pp-0.3 pp2nd highest of 21
EV / EBITDA7.6×13.5×2nd cheapest of 13
Net debt / EBITDA2.4×1.0×4th most indebted of 14

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Ingevity NGVTUnited States$1.97B-12%-12%26%10.2×-1.4%-0.8%
Eternal Materials 1717.TWTaiwan$1.96B-29%+7%6%14.8×14.5%+1.2%
Innospec IOSPUnited States$1.94B0%+5%8%13.8×5.0%+8.3%
Advanced Echem Materials 4749.TWOTaiwan$1.93B-34%+20%25%33.6×n/an/a
Hubei Sinophorus Electronic Materials 688545.SSChina$2.07B-39%+75%11%62.9×n/an/a
Zhejiang Yongtai Technology 002326.SZChina$1.81B-44%+38%11%n/an/an/a
Fine Organic Industries FINEORG.NSIndia$1.81B+21%+13%20%33.4×28.7%+15.7%
AARTI Industries AARTIIND.NSIndia$1.80B-1%+40%9%29.9×n/an/a
Nippon Shokubai 4114.TJapan$2.24B+16%+8%6%17.4×n/an/a
Nippon Kayaku 4272.TJapan$1.71B-9%+16%10%10.5×1.7%+6.9%
Alzchem ACT0.DEGermany$1.68Bn/a+5%16%23.1×0.5%+8.2%
Aether Industries AETHER.NSIndia$2.34B+50%+31%25%76.6×n/an/a
Isuspecialtychemical 457190.KSSouth Korea$1.62B-32%+6%2%n/an/an/a
Valiant 002643.SZChina$1.61B-36%+3%10%26.1×17.1%+4.9%
Huntsman HUNUnited States$1.58B-36%+6%0%n/an/an/a
Borregaard BRG.OLNorway$1.58B+6%+3%17%24.0×-1.2%+7.7%
Grandit 688549.SSChina$2.66B-7%+40%-1%n/an/an/a
Privi Speciality Chemicals PRIVISCL.NSIndia$1.44B+11%+18%20%36.4×30.6%+15.0%
Xinxiang Richful Lube Additive 300910.SZChina$1.36B-33%+12%16%12.2×2.1%+32.5%
Hanchem 014680.KSSouth Korea$1.35B-49%+11%17%11.6×5.8%+7.4%
Rianlon 300596.SZChina$1.35B-15%+11%11%14.2×n/an/a

Questions

Who are Ingevity's main competitors?
Named competitors: Kraton Corporation (private or unlisted), Cabot Corporation (CBT), Kuraray (3405.T). The cockpit's measured peer set (industry) also includes Eternal Materials (1717.TW), Innospec (IOSP), Advanced Echem Materials (4749.TWO), Hubei Sinophorus Electronic Materials (688545.SS), Zhejiang Yongtai Technology (002326.SZ), Fine Organic Industries (FINEORG.NS).
Is Ingevity expensive compared with its peers?
On forward p/e it trades at 10.2× against a peer median of 23.5×, cheapest of 17 in its peer set. For today's price to make sense, revenue must grow about -1% a year for seven years (Req g). Recent delivered growth is -1%, so the hurdle is -1 pp: the price already allows for a slowdown.
How has Ingevity stock performed?
Over six months to 18 Nov 2026 the shares returned -11.8% against -14.8% for the median peer; over one year +23.8%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.